Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 112 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Anagnostis, Panagiotis [Clear All Filters]
Association between lifestyle and anthropometric parameters and thyroid nodule features..
Endocrine. 56(3), 560-567.
(2017). The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis..
Maturitas. 99, 27-36.
(2017). Vitamin D Supplementation and Cardiovascular Disease Risk..
JAMA Cardiol. 2(11), 1281-1282.
(2017). Androgen excess and post-reproductive health..
Maturitas. 115, 115-116.
(2018). Calcium and Vitamin D Supplements and Fractures in Community-Dwelling Adults..
JAMA. 319(19), 2041.
(2018). The combined effect of vitamin D and parathyroid hormone concentrations on glucose homeostasis in older patients with prediabetes: A cross-sectional study..
Diab Vasc Dis Res. 15(2), 150-153.
(2018). Diabetes and Atherosclerosis: Old Players in a New Field, Osteoporosis..
Curr Vasc Pharmacol. 16(6), 524-527.
(2018). Diet and lifestyle for post-reproductive health: Focus on diabetes..
Case Rep Womens Health. 18, e00056.
(2018). Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?.
Maturitas. 108, 45-52.
(2018). The effect of antidiabetic medications on the cardiovascular system: a critical appraisal of current data..
Hormones (Athens). 17(1), 83-95.
(2018). Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review..
Endocrine. 60(3), 373-383.
(2018). Letter to the Editor: "Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program"..
J Clin Endocrinol Metab. 103(5), 2066-2067.
(2018). Management of Acute Hip Fracture..
N Engl J Med. 378(10), 971-2.
(2018). Weight loss for the prevention and treatment of type 2 diabetes..
Maturitas. 108, A1-A2.
(2018). Association between age at menopause and fracture risk: a systematic review and meta-analysis..
Endocrine. 63(2), 213-224.
(2019). Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss..
Expert Opin Pharmacother. 20(9), 1123-1134.
(2019). Diabetes in Menopause: Risks and Management..
Curr Vasc Pharmacol. 17(6), 556-563.
(2019). Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis..
Eur J Endocrinol. 180(1), 41-50.
(2019). The Emerging Role of Bone Markers in Diagnosis and Risk Stratification of Patients With Coronary Artery Disease..
Angiology. 70(8), 690-700.
(2019). "Holidays" for osteoporosis drugs: A case-based approach..
Case Rep Womens Health. 23, e00127.
(2019). Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease"..
J Clin Endocrinol Metab. 104(8), 3124.
(2019). Management of dyslipidaemias in the elderly population-A narrative review..
Maturitas. 124, 93-99.
(2019). Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?.
Curr Vasc Pharmacol. 17(6), 564-572.
(2019). Menopause and its Cardiometabolic Consequences: Current Perspectives..
Curr Vasc Pharmacol. 17(6), 543-545.
(2019). New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019).